Related Experiment Video
Updated: Jan 4, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Late-onset Pompe disease associated with polyneuropathy
M Lamartine S Monteiro1, G Remiche1
1Centre de Référence Neuromusculaire, Department of Neurology, Service de Neurologie, Hôpital Erasme, Université Libre de Bruxelles (ULB), Route de Lennik 808, 1070 Brussels, Belgium.
Late-onset Pompe disease can affect peripheral nerves, including large nerve fibers, a previously undocumented finding. This discovery highlights the need for careful neurological assessment and specialized care in patients with this rare genetic disorder.
Area of Science:
- Neurology
- Genetics
- Metabolic Disorders
Background:
- Late-onset Pompe disease (LOPD) results from glycogen accumulation, primarily affecting striated muscle.
- While LOPD is known to impact various tissues, peripheral nerve involvement, particularly in Schwann cells and perineurium, has been observed in mouse models.
- Previous reports in human LOPD patients have suggested small fiber neuropathy, but large nerve fiber involvement remained uncharacterized.
Observation:
- This study details four LOPD patients presenting with a concurrent polyneuropathy of unknown cause.
- The observed polyneuropathy involved both small and large nerve fibers, indicating a broader neurological impact than previously understood.
Findings:
- The findings demonstrate a significant association between late-onset Pompe disease and polyneuropathy.
- This research provides the first evidence of large nerve fiber involvement in the peripheral nervous system of LOPD patients.
Implications:
- Peripheral nerve involvement in LOPD can exacerbate patient disability and requires specific management strategies.
- These findings underscore the importance of comprehensive neurological evaluations in LOPD patients to include assessment of peripheral neuropathy.
- Specialized care, such as proprioceptive physiotherapy, may be crucial for managing LOPD-associated neuropathy and improving patient outcomes.
More Related Videos
08:16Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
06:35In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Long-term Potentiation
Long-term Potentiation
Hebbian LTP
LTP can occur when...
Lysosomal Hydrolases
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation